IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for ...

Paramount Skydance operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various ...

NatWest Group derives around 90% of its total income from the United Kingdom. The bank operates a retail, commercial, and private bank in the UK, offering clients lending and payment services as well ...

Get the latest news, fund ideas, market commentary and opinions from Fidelity’s savings and investment experts on investing ...

The investment objective of the Fund is to seek to outperform the UK Consumer Price Index (“CPI”) over five-year periods with a target of generating a positive absolute return on a rolling three-year ...

The Phoenix Wealth Aquila Connect Global Equity 50/50 Index Fund invests in the Aquila Connect Global Equity 50/50 Index Fund. The objective of the Aquila Connect Global Equity 50/50 Index Fund is to ...

The Fund aims to achieve long-term (5 years plus) capital growth. The Fund invests at least 80% of its assets in shares or other equity related securities of companies globally, excluding the UK. In ...

The Fund seeks to provide income and capital growth, with a focus on income, over the long term (a period of at least 5 years). The Fund is classified as ‘Cautious’ or risk profile 2 in the Barclays ...

Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising ...

The fund aims to achieve capital growth over the long term. The fund invests at least 70% of its assets, in equities of companies that are headquartered or do most of their business in less developed ...

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs ...